Literature DB >> 9632748

Cyclin-stimulated binding of Cks proteins to cyclin-dependent kinases.

E A Egan1, M J Solomon.   

Abstract

Although Cks proteins were the first identified binding partners of cyclin-dependent protein kinases (cdks), their cell cycle functions have remained unclear. To help elucidate the function of Cks proteins, we examined whether their binding to p34(cdc2) (the mitotic cdk) varies during the cell cycle in Xenopus egg extracts. We observed that binding of human CksHs2 to p34(cdc2) was stimulated by cyclin B. This stimulation was dependent on the activating phosphorylation of p34(cdc2) on Thr-161, which follows cyclin binding and is mediated by the cdk-activating kinase. Neither the inhibitory phosphorylations of p34(cdc2) nor the catalytic activity of p34(cdc2) was required for this stimulation. Stimulated binding of CksHs2 to another cdk, p33(cdk2), required both cyclin A and activating phosphorylation. Our findings support recent models that suggest that Cks proteins target active forms of p34(cdc2) to substrates.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632748      PMCID: PMC108948          DOI: 10.1128/MCB.18.7.3659

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  59 in total

Review 1.  Cell cycle: reaching for a role for the Cks proteins.

Authors:  J Pines
Journal:  Curr Biol       Date:  1996-11-01       Impact factor: 10.834

2.  Binding of activated cyclosome to p13(suc1). Use for affinity purification.

Authors:  V Sudakin; M Shteinberg; D Ganoth; J Hershko; A Hershko
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

3.  Reversible phosphorylation controls the activity of cyclosome-associated cyclin-ubiquitin ligase.

Authors:  S Lahav-Baratz; V Sudakin; J V Ruderman; A Hershko
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

4.  A 20S complex containing CDC27 and CDC16 catalyzes the mitosis-specific conjugation of ubiquitin to cyclin B.

Authors:  R W King; J M Peters; S Tugendreich; M Rolfe; P Hieter; M W Kirschner
Journal:  Cell       Date:  1995-04-21       Impact factor: 41.582

5.  p13suc1 of Schizosaccharomyces pombe regulates two distinct forms of the mitotic cdc2 kinase.

Authors:  G Basi; G Draetta
Journal:  Mol Cell Biol       Date:  1995-04       Impact factor: 4.272

6.  The subunit composition of mammalian cytochrome c oxidase.

Authors:  P Merle; B Kadenbach
Journal:  Eur J Biochem       Date:  1980-04

7.  Sucl+ encodes a predicted 13-kilodalton protein that is essential for cell viability and is directly involved in the division cycle of Schizosaccharomyces pombe.

Authors:  J Hindley; G Phear; M Stein; D Beach
Journal:  Mol Cell Biol       Date:  1987-01       Impact factor: 4.272

8.  The Saccharomyces cerevisiae CKS1 gene, a homolog of the Schizosaccharomyces pombe suc1+ gene, encodes a subunit of the Cdc28 protein kinase complex.

Authors:  J A Hadwiger; C Wittenberg; M D Mendenhall; S I Reed
Journal:  Mol Cell Biol       Date:  1989-05       Impact factor: 4.272

9.  The function(s) of CAK, the p34cdc2-activating kinase.

Authors:  M J Solomon
Journal:  Trends Biochem Sci       Date:  1994-11       Impact factor: 13.807

10.  The MO15 gene encodes the catalytic subunit of a protein kinase that activates cdc2 and other cyclin-dependent kinases (CDKs) through phosphorylation of Thr161 and its homologues.

Authors:  D Fesquet; J C Labbé; J Derancourt; J P Capony; S Galas; F Girard; T Lorca; J Shuttleworth; M Dorée; J C Cavadore
Journal:  EMBO J       Date:  1993-08       Impact factor: 11.598

View more
  6 in total

1.  Cks1 is required for G(1) cyclin-cyclin-dependent kinase activity in budding yeast.

Authors:  G J Reynard; W Reynolds; R Verma; R J Deshaies
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

2.  CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms.

Authors:  Fenghuang Zhan; Simona Colla; Xiaosong Wu; Bangzheng Chen; James P Stewart; W Michael Kuehl; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2007-02-15       Impact factor: 22.113

3.  Upregulation of topoisomerase IIalpha expression in advanced gallbladder carcinoma: a potential chemotherapeutic target.

Authors:  Mitsutsune Washiro; Masayuki Ohtsuka; Fumio Kimura; Hiroaki Shimizu; Hiroyuki Yoshidome; Takashi Sugimoto; Naohiko Seki; Masaru Miyazaki
Journal:  J Cancer Res Clin Oncol       Date:  2008-01-17       Impact factor: 4.553

4.  Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance.

Authors:  Lei Shi; Siqing Wang; Maurizio Zangari; Hongwei Xu; Thai M Cao; Chunjiao Xu; Yong Wu; Fang Xiao; Yinghong Liu; Ye Yang; Mohamed Salama; Guiyuan Li; Guido Tricot; Fenghuang Zhan
Journal:  Oncotarget       Date:  2010-05

Review 5.  Genetic diagnosis of subfertility: the impact of meiosis and maternal effects.

Authors:  Alexander Gheldof; Deborah J G Mackay; Ying Cheong; Willem Verpoest
Journal:  J Med Genet       Date:  2019-02-06       Impact factor: 6.318

6.  The CDK subunit CKS2 counteracts CKS1 to control cyclin A/CDK2 activity in maintaining replicative fidelity and neurodevelopment.

Authors:  Mattia Frontini; Alexander Kukalev; Elisabetta Leo; Yiu-Ming Ng; Marcella Cervantes; Chi-Wai Cheng; Roman Holic; Dirk Dormann; Eric Tse; Yves Pommier; Veronica Yu
Journal:  Dev Cell       Date:  2012-08-14       Impact factor: 12.270

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.